Aug 17, 2020
Immutep Completes Recruitment for Stage 1 of Part B in TACTI-002 Study
Immutep Issues Newsletter Update to Shareholders
Aug 11, 2020
Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination
Jul 22, 2020
Immutep Quarterly Activities Report
Jul 13, 2020
Immutep Announces United States Patent Grant for IMP701 Antibody
